-
Zelluna ASA [ZLNA]: The first ever cell therapy company to list on the Oslo Stock Exchange following successful completion of the business combination and private placement
-
Ultimovacs ASA: Approval and publication of prospectus
-
Ultimovacs ASA: Cancellation of subsequent repair offering
-
Ultimovacs ASA Reports Fourth Quarter 2024 Financial Results and Provides General Business Update
-
Ultimovacs ASA: Invitation to fourth quarter 2024 results webcast presentation
-
Ultimovacs ASA: Notification of major holdings
-
Ultimovacs ASA – Extraordinary General Meeting held on January 9, 2025
-
Ultimovacs ASA – Disclosure of voting rights of Extraordinary General Meeting
-
Ultimovacs ASA – Disclosure of voting rights of Extraordinary General Meeting
-
Ultimovacs ASA: Regarding the extraordinary general meeting on 9 January 2025
